JZJingting Zhu

Jingting Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jingting Zhu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Andre Boonstra

    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands

    1 shared publication
  • Claudia E. Mulders

    Department of Viroscience Erasmus University Medical Center Rotterdam The Netherlands

    1 shared publication
  • Gertine W. van Oord

    Department of Gastroenterology and Hepatology Erasmus University Medical Center Rotterdam The Netherlands

    1 shared publication
  • Gulce Sari

    Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands

    1 shared publication
  • Jia Meng

    Department of Biosciences and Bioinformatics, Center for Intelligent RNA Therapeutics, Suzhou Key Laboratory of Cancer Biology and Chronic Disease, School of Science, Xi'an Jiaotong-Liverpool University , Suzhou, Jiangsu 215123

    1 shared publication
  • Jolanda J. C. Voermans

    Department of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Treatment induced clearance of hepatitis E viruses by interferon‐lambda in liver‐humanized mice

    by Gulce Sari, Claudia E. Mulders, Jingting Zhu, Gertine W. van Oord, Zongdi Feng, Jolanda J.C. Kreeft‐Voermans, Andre Boonstra, Thomas Vanwolleghem

    Background: Hepatitis E viruses (HEV) are an underestimated global cause of enterically transmitted viral hepatitis, which may persist in immunocompromised hosts, posing a risk for progressive liver fibrosis with limited treatment options. We previously established liver‐humanized mice as a model for chronic HEV infections, which can be cleared by a 2‐week pegylated (peg)‐Interferon(IFN)α treatment course. However, severe side effects may hamper the use of IFNα in immunocompromised transplant recipient patients. IFNλ may be a valuable alternative, as its receptor is less ubiquitously expressed.Aims: In this study, we assess the in vitro and in vivo potency of pegIFNλ to induce innate immune signalling in liver cells and to clear a persistent HEV infection in liver‐humanized mice.Methods & Results: We found that human liver cells expressed the IFNλ receptor (IFNLR1) and are responsive to pegIFNλ. Treatment with pegIFNλ of liver‐humanized mice persistently infected with HEV genotype 3 showed that pegIFNλ was well tolerated. Dose escalation studies showed that although HEV was not cleared at pegIFNλ doses up to 0.12 mg/kg for a maximum of 8 weeks, a dose of 0.3 mg/kg pegIFNλ treatment resulted in complete clearance of HEV antigen and HEV RNA from the liver in 8 out of 9 liver‐humanized mice.Conclusions: PegIFNλ is well tolerated in mice and leads to clearance of a persistent HEV infection in liver‐humanized mice.


  • Open Access

    Autophagy Induced by Simian Retrovirus Infection Controls Viral Replication and Apoptosis of Jurkat T Lymphocytes

    by Jingting Zhu, Lingyan Yang, Qibo Zhang, Jia Meng, Zhi-Liang Lu, Rong Rong

    Autophagy and apoptosis are two important evolutionarily conserved host defense mechanisms against viral invasion and pathogenesis. However, the association between the two pathways during the viral infection of T lymphocytes remains to be elucidated. Simian type D retrovirus (SRV) is an etiological agent of fatal simian acquired immunodeficiency syndrome (SAIDS), which can display disease features that are similar to acquired immunodeficiency syndrome in humans. In this study, we demonstrate that infection with SRV-8, a newly isolated subtype of SRV, triggered both autophagic and apoptotic pathways in Jurkat T lymphocytes. Following infection with SRV-8, the autophagic proteins LC3 and p62/SQSTM1 interacted with procaspase-8, which might be responsible for the activation of the caspase-8/-3 cascade and apoptosis in SRV-8-infected Jurkat cells. Our findings indicate that autophagic responses to SRV infection of T lymphocytes promote the apoptosis of T lymphocytes, which, in turn, might be a potential pathogenetic mechanism for the loss of T lymphocytes during SRV infection.